Overview

Antibiotic Loaded Cement After TKA

Status:
Enrolling by invitation
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This study will provide us with clear information about the postoperative concentration of antibiotic reached in synovial fluid, thereby helping surgeons to determine if concentration could potentially prevent the growth and regrowth of common infecting microorganisms (based on their MIC and MBEC). There is a need to define the actual benefit of antibiotic-loaded bone cement, because the addition of antibiotic can reduce its mechanical strength. Moreover, if sub-therapeutic antibiotic levels are achieved, this could facilitate the emergence of resistant bacterial strains. Amidst the transition towards value-based care, our research will enable surgeons to decide whether antibiotic-loaded cement is truly cost-effective in the prevention of PJI.
Phase:
Phase 3
Details
Lead Sponsor:
Rothman Institute Orthopaedics
Treatments:
Anti-Bacterial Agents
Gentamicins
Tobramycin